Skip to main content

Mineralys Therapeutics, Inc.

MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001933414

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Mineralys Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
215
−5 vs. Q4 2025
Shares held
90.3M
+5.56M (+6.6%) vs. Q4 2025
Total value
$2.46B
−$621.1M (−20.2%) vs. Q4 2025
New holders
33
98 more added
Sold out
38
52 more reduced

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MLYS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 215 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 68 institutionsQ2 2023: 68 institutionsQ3 2023: 77 institutionsQ4 2023: 87 institutionsQ1 2024: 92 institutionsQ2 2024: 94 institutionsQ3 2024: 106 institutionsQ4 2024: 109 institutionsQ1 2025: 149 institutionsQ2 2025: 166 institutionsQ3 2025: 193 institutionsQ4 2025: 223 institutionsQ1 2026: 215 institutionsQ2 2026: 225 institutions
Value heldQ1 2026: $2.46B
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $385.4MQ2 2023: $429.2MQ3 2023: $252.1MQ4 2023: $298.5MQ1 2024: $540.6MQ2 2024: $516.6MQ3 2024: $540.1MQ4 2024: $572.2MQ1 2025: $966.2MQ2 2025: $888.8MQ3 2025: $3.01BQ4 2025: $3.21BQ1 2026: $2.46BQ2 2026: $2.69B
Institutions holding MLYS and their total value by quarter
QuarterHoldersValue
Q2 2026225$2.69B
Q1 2026215$2.46B
Q4 2025223$3.21B
Q3 2025193$3.01B
Q2 2025166$888.8M
Q1 2025149$966.2M
Q4 2024109$572.2M
Q3 2024106$540.1M
Q2 202494$516.6M
Q1 202492$540.6M
Q4 202387$298.5M
Q3 202377$252.1M
Q2 202368$429.2M
Q1 202368$385.4M
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Mineralys Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding MLYS in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Sr One Capital Management, LP1,563,966$42.4M4.63%00.0%Unchanged
Andera Partners1,591,917$43.1M24.38%00.0%Unchanged
Franklin Resources Inc1,784,662$48.3M0.01%−4,085−0.2%Reduced
Point72 Asset Management, L.P.1,911,433$51.8M0.09%+704,213+58.3%Added
OrbiMed Advisors LLC2,052,900$55.6M1.26%+1,072,500+109.4%Added
Laurion Capital Management LP2,232,040$60.5M5.67%+518,555+30.3%Added
Vanguard Capital Management LLC2,454,363$66.5M0.00%+2,454,363New
Caligan Partners LP2,772,654$75.1M5.31%00.0%Unchanged
State Street Corp2,935,940$79.5M0.00%−249,059−7.8%Reduced
Wellington Management Group LLP3,359,068$91.0M0.02%+2,574,801+328.3%Added
BlackRock, Inc.4,481,582$121.4M0.00%+153,904+3.6%Added
FMR LLC4,861,104$131.7M0.01%−196,405−3.9%Reduced
Samsara BioCapital, LLC5,871,018$159.0M15.45%00.0%Unchanged
Ra Capital Management, L.P.7,692,750$208.4M2.21%+369,000+5.0%Added
Catalys Pacific, LLC7,903,838$214.1M92.81%00.0%Unchanged
Holocene Advisors, LP0$00.00%−1,602,035−100.0%Sold out
Samlyn Capital, LLC0$00.00%−1,304,932−100.0%Sold out
Capital International Investors0$00.00%−1,163,290−100.0%Sold out
Farallon Capital Management, L.L.C.0$00.00%−823,296−100.0%Sold out
Siren, L.L.C.0$00.00%−699,999−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−353,700−100.0%Sold out
Ikarian Capital, LLC0$00.00%−200,000−100.0%Sold out
Simplify Asset Management Inc.0$00.00%−114,182−100.0%Sold out
EAM Investors, LLC0$00.00%−96,135−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−94,983−100.0%Sold out
Blue Owl Capital Holdings LP0$00.00%−65,944−100.0%Sold out
Winton Group Ltd0$00.00%−64,806−100.0%Sold out
Moore Capital Management, LP0$00.00%−60,000−100.0%Sold out
Zimmer Partners, LP0$00.00%−57,500−100.0%Sold out
Sigma Planning Corp0$00.00%−24,000−100.0%Sold out
Atom Investors LP0$00.00%−22,330−100.0%Sold out
Maven Securities LTD0$00.00%−20,000−100.0%Sold out
Twin Securities, Inc.0$00.00%−16,737−100.0%Sold out
PSP Research LLC0$00.00%−14,818−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−14,404−100.0%Sold out
Optimize Financial Inc0$00.00%−12,383−100.0%Sold out
Quest Partners LLC0$00.00%−11,328−100.0%Sold out
FORA Capital, LLC0$00.00%−11,050−100.0%Sold out
Mariner, LLC0$00.00%−10,230−100.0%Sold out
Banque Pictet & Cie SA0$00.00%−7,486−100.0%Sold out
Cinctive Capital Management LP0$00.00%−7,037−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−6,860−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−6,781−100.0%Sold out
NEOS Investment Management LLC0$00.00%−6,463−100.0%Sold out
Tema ETFs LLC0$00.00%−6,463−100.0%Sold out
Arrowpoint Investment Partners (Singapore) Pte. Ltd.0$00.00%−6,384−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−3,823−100.0%Sold out
Acadian Asset Management LLC0$00.00%−2,908−100.0%Sold out
Amalgamated Bank0$00.00%−1,470−100.0%Sold out
Navalign, LLC0$00.00%−900−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−235−100.0%Sold out
Torren Management, LLC0$00.00%−39−100.0%Sold out
Bessemer Group Inc0$00.00%−38−100.0%Sold out
Vanguard Group Inc––––Not filed
Iron Triangle Partners LP––––Not filed
Comerica Bank––––Not filed